Related Experiment Video
Updated: Mar 27, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Apolipoprotein AI is a protective factor for idiopathic sudden sensorineural hearing loss: a two-sample mendelian
Fuzhi Lin1, Wei Wu2, Fengfei Tan2
1Department of Otorhinolaryngology-Head and Neck Surgery, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Objective:
Observational studies have suggested an association between cardiometabolic factors and idiopathic sudden sensorineural hearing loss (ISSNHL), but the causal relationship remains unclear. We aimed to assess the causal effect of cardiometabolic factors on the risk of ISSNHL using a two-sample Mendelian randomisation (MR) approach.
Design:
Two-sample MR study.
Study Sample:
We used summary-level data from genome-wide association studies (GWAS). Genetic instruments for cardiometabolic factors were obtained from GWAS. Summary statistics for ISSNHL were derived from a publicly available GWAS database.
Results:
Genetically predicted higher ApoAI levels were significantly associated with an decreased risk of ISSNHL (IVW OR = 0.82, 95% CI: 0.68-0.98, P = 0.03). No evidence of directional pleiotropy was detected in MR-Egger regression (P = 0.30), and Cochran's Q test indicated no significant heterogeneity (P = 0.94). MR-PRESSO detected no outliers.
Conclusion:
This study provides evidence supporting a potential causal relationship between higher ApoAI levels and decreased risk of ISSNHL. Further biological and clinical studies are warranted to elucidate the underlying mechanisms.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
Single Nucleotide Polymorphisms-SNPs
Pharmacogenomics: Identification of New Drug Targets
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pleiotropy